LSTA
Lisata Therapeutics Inc
$1.17
0.04 (3.54%) Today
0.08 (7.34%) After-hours
— up— down
Market Cap
$10M-57.4%
Revenue (TTM)
$175.82K-27.1%
Net Income (TTM)
$-17,422,875
$-17,422,875EPS (TTM)
-1.91
-1.91Shares Out
9.11M
9.11MOpen
$1.10
$1.10Previous Close
$1.13
$1.13Day Range
$1.05 – $1.15
$1.05 – $1.1552-Week Range
$0.99 – $5.07
$0.99 – $5.07Beta
0.90
0.90Volume
23.57K
23.57KAvg Volume
112.11K
112.11KAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout LSTA
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
Related
News
N/AN/AN/AN/AN/A
Mount Etna erupts in fiery display, disrupting hundreds of flights - Reuters
Reuters · 1h ago
UAE's ADNOC says one of its vessels came under attack while transiting Hormuz - Reuters
Reuters · 3h ago
Hormuz traffic slows further after US threatens more economic pressure on Iran - Reuters
Reuters · 3h ago
Iran defiant on strait as Trump tells Americans to accept high gas prices - Reuters
Reuters · 5h ago
Oil climbs over $1 on tanker attacks, no progrees on peace - Reuters
Reuters · 7h ago